Genkyotex develops drugs to block the NOX enzymes that produce oxygen radicals, targeting therapeutic areas of cardiovascular, metabolic, and neurodegenerative diseases
Genkyotex develops drugs to block the NOX enzymes that produce oxygen radicals, targeting therapeutic areas of cardiovascular, metabolic, and neurodegenerative diseases.